• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 02 Feb 2026

Stabilizing U.S. Staffing Client Demand In 2026 Augurs Well For TBI, In Our View; Strong Free Cash Flow And The Solid Earnings Rebound We Project Support Our Street High $10 Target


Trueblue (TBI:NYSE) | 0 0 0.0%


  • Sidoti & Company
    • Marc Riddick, CFA

    • 10 pages


 

According to Staffing Industry Analysts (SIA), the staffing market in the United States is expected to grow 2% in 2026, led by gains in healthcare, technology and skilled trades. We think staffing stocks in general, and TrueBlue in particular, are poised for strong gains in an improving client demand environment. Management provided guidance last November on select line 4Q:25 items, including revenue of $399-$424 million. We maintain our forecasted loss per share of $0.51 in 2025, followed by EPS of $0.49 in 2026 and $0.88 in 2027. We maintain our free cash flow (excluding the add back of stock-based compensation expense) per share estimates of $0.49 in 2025, $1.17 in 2026 and $1.69 in 2027, which imply FCF yields of 9.2%, 21.9% and 31.6%, respectively. Our $10 price target is based on 10x our 2027 EPS estimate of $0.88, plus projected 2027 yearend net cash per share of $0.94. On a P/E-only basis, our target implies an 11.4x multiple to our 2027 EPS estimate. Shares of TrueBlue have traded at an average forward P/E multiple of 13.2x over the last decade, slightly below our 5-year EPS CAGR of 14%. The company's solid balance sheet and strong free cash flow support both the valuation and our moderate risk rating, in our view.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

Stabilizing U.S. Staffing Client Demand In 2026 Augurs Well For TBI, In Our View; Strong Free Cash Flow And The Solid Earnings Rebound We Project Support Our Street High $10 Target


Trueblue (TBI:NYSE) | 0 0 0.0%


  • Published: 02 Feb 2026
  • Author: Marc Riddick, CFA
  • Pages: 10
  • Sidoti & Company


According to Staffing Industry Analysts (SIA), the staffing market in the United States is expected to grow 2% in 2026, led by gains in healthcare, technology and skilled trades. We think staffing stocks in general, and TrueBlue in particular, are poised for strong gains in an improving client demand environment. Management provided guidance last November on select line 4Q:25 items, including revenue of $399-$424 million. We maintain our forecasted loss per share of $0.51 in 2025, followed by EPS of $0.49 in 2026 and $0.88 in 2027. We maintain our free cash flow (excluding the add back of stock-based compensation expense) per share estimates of $0.49 in 2025, $1.17 in 2026 and $1.69 in 2027, which imply FCF yields of 9.2%, 21.9% and 31.6%, respectively. Our $10 price target is based on 10x our 2027 EPS estimate of $0.88, plus projected 2027 yearend net cash per share of $0.94. On a P/E-only basis, our target implies an 11.4x multiple to our 2027 EPS estimate. Shares of TrueBlue have traded at an average forward P/E multiple of 13.2x over the last decade, slightly below our 5-year EPS CAGR of 14%. The company's solid balance sheet and strong free cash flow support both the valuation and our moderate risk rating, in our view.

More Content

More Content

Reported 3Q:25 EPS Exceeds Our Estimate Due To Revenue And Margin Outperformance; We Reduce Our 2026 Estimate And Introduce Our 2027 Forecast; Trim Price Target To $10 (From $11)

Companies: Trueblue

Sidoti & Company

With Changes In Ownership, Board Membership And A New CEO, We Think There Is Potential For Updated Strategic Direction; Strong Free Cash Flow And Balance Sheet Support Our $20 Target

Companies: KELLY SERVICES INC -A

Sidoti & Company

Our 3Q:25 Loss Per Share Estimate Is Based On Anticipated Revenue Growth Over The Prior-Year Period; Free Cash Flow, EPS Growth Resumption In 2026 And Valuation Support Our $11 Target

Companies: Trueblue

Sidoti & Company

Hybridan Small Cap Feast: 29 January 2026

Companies: CDGP EMR SML HVO KRM SEA GWMO APTA UFO

Hybridan

Reported 2Q:25 Loss Per Share Exceeds Our Estimate, Led By Reduced Expenses; Revenue Guidance For 3Q:25 That Is Above Our Forecast And Improving Trends Support $11 Price Target

Companies: Trueblue

Sidoti & Company
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2026

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Morphose Capital Partners
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS Research Group
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Curious Compounder
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • ISTAR Capital
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • ISTAR Capital
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In